» Articles » PMID: 38455876

Developing International Classification of Disease Code Definitions for the Study of Enteric Infection Sequelae in Canada

Abstract

Background: Enteric infections and their chronic sequelae are a major cause of disability and death. Despite the increasing use of administrative health data in measuring the burden of chronic diseases in the population, there is a lack of validated International Classification of Disease (ICD) code-based case definitions, particularly in the Canadian context. Our objective was to validate ICD code definitions for sequelae of enteric infections in Canada: acute kidney injury (AKI); hemolytic uremic syndrome (HUS); thrombotic thrombocytopenic purpura (TTP); Guillain-Barré syndrome/Miller-Fisher syndrome (GBS/MFS); chronic inflammatory demyelinating polyneuropathy (CIDP); ankylosing spondylitis (AS); reactive arthritis; anterior uveitis; Crohn's disease, ulcerative colitis, celiac disease, erythema nodosum (EN); neonatal listeriosis (NL); and Graves' disease (GD).

Methods: We used a multi-step approach by conducting a literature review to identify existing validated definitions, a clinician assessment of the validated definitions, a chart review to verify proposed definitions and a final clinician review. We measured the sensitivity and positive predictive value (PPV) of proposed definitions.

Results: Forty studies met inclusion criteria. We identified validated definitions for 12 sequelae; clinicians developed three (EN, NL, GD). We reviewed 181 charts for 6 sequelae (AKI, HUS, TTP, GBS/MFS, CIDP, AS). Sensitivity (42.8%-100%) and PPV (63.6%-100%) of ICD code definitions varied. Six definitions were modified by clinicians following the chart review (AKI, TTP, GBS/MFS, CIDP, AS, reactive arthritis) to reflect coding practices, increase specificity or sensitivity, and address logistical constraints.

Conclusion: The multi-step design to derive ICD code definitions provided flexibility to identify existing definitions, to improve their sensitivity and PPV and adapt them to the Canadian context.

Citing Articles

Validating ICD-10 Diagnosis Codes for Guillain-Barré Syndrome in Taiwan's National Health Insurance Claims Database.

Hsieh C, Chen P, Shao S, Lin S, Liao S, Lai E Clin Epidemiol. 2024; 16:733-742.

PMID: 39445227 PMC: 11497080. DOI: 10.2147/CLEP.S485953.

References
1.
Marrie R, Fisk J, Stadnyk K, Tremlett H, Wolfson C, Warren S . Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia. Chronic Dis Inj Can. 2014; 34(2-3):145-53. View

2.
Chang H, Tserenpuntsag B, Kacica M, Smith P, Morse D . Hemolytic uremic syndrome incidence in New York. Emerg Infect Dis. 2004; 10(5):928-31. PMC: 3323227. DOI: 10.3201/eid1005.030456. View

3.
Waikar S, Wald R, Chertow G, Curhan G, Winkelmayer W, Liangos O . Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol. 2006; 17(6):1688-94. DOI: 10.1681/ASN.2006010073. View

4.
Jiang G, de Pedro-Cuesta J, Fredrikson S . Guillain-Barré syndrome in south-west Stockholm, 1973-1991, 1. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand. 1995; 91(2):109-17. DOI: 10.1111/j.1600-0404.1995.tb00416.x. View

5.
Tam C, Rodrigues L, Petersen I, Islam A, Hayward A, OBrien S . Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis. 2006; 194(1):95-7. DOI: 10.1086/504294. View